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Letter by Urra et al Regarding Article,
“Autoimmune Responses to the Brain After
Stroke Are Associated With Worse Outcome”
To the Editor:
The prognostic and therapeutic implications of immunity in
stroke are very promising. Becker et al recently described that
immune responses to various brain antigens can be found in
patients after stroke.1 This study confirms previous reports
suggesting the presence of such autoimmune responses in human
stroke.2,3 The study further describes that 90-day outcome was
mainly associated to autoimmunity to myelin basic protein,
raising the question of whether the consequences of autoimmu-
nity vary depending on the antigen specificity, which would be
an indication of a complex crosstalk between the central nervous
system and the immune system after stroke. However, we would
like to make some clarifications, especially on some of the
conclusions regarding the relevance of infection in the promotion
of autoimmunity.
The conclusion that the risk of developing an inflammatory
response to myelin basic protein is increased by infection is not
supported by the data because stroke severity is a major risk
factor for infection but is also associated with the immune
responses in the study. In fact, the authors explain that the effect
of infection on immunologic outcome was lost after controlling
for stroke severity. In addition, it would be most interesting to
know if infection was an independent predictor of poor outcome
in this study, because the possibility is extensively discussed by
the authors but not reported in the results and previous literature
is largely contradictory on this topic.4,5
Also, it is questionable whether these results show that the
response to brain antigens predicts long-term outcome as stated
in the summary because 90-day outcome was only associated
with immune responses at 90 days but not with those in the acute
phase. Further studies will certainly help unravel the significance
of these autoimmune responses at different times and identify
their prognostic consequences and hopefully also the best ther-
apeutic targets.
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